A Study To Evaluate ASN002 In Subjects With Atopic Dermatitis

NCT03139981 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Dermatitis, Atopic
Dermatitis Eczema
Dermatitis, Eczematous

Interventions

DRUG: ASN002
DRUG: Placebo Oral Tablet

Sponsor

Asana BioSciences